A highly cephem-resistant Escherichia coli strain, FP1546, isolated from the fecal flora of laboratory dogs previously administered 1-lactam antibiotics was found to produce a P-lactamase, FEC-1, of 48-kilodalton size and pl 8.2. FEC-1 hydrolyzed cefuroxime, cefotaxime, cefmenoxime, and ceftriaxone, as well as the enzymatically less-stable antibiotics cephaloridine, cefotiam, and cefpiramide. Of the oxyimino-cephalosporins, ceftizoxime was fairly stable to FEC-1. FEC-1 differed notably from chromosomal E. coli cephalosporinase, especially in its broad-spectrum substrate profile and its high inhibition by clavulanic acid, sulbactam, and imipenem. A conjugation study revealed that FEC-1 was encoded by a 74-megadalton plasmid, pFCX1. This may be the first instance of a plasmid-mediated oxyimino-cephalosporinase from E. coli.
teria as members of the family Enterobacteriaceae, Pseudomonas aeruginosa, Haemophilus influenzae, and Neisseria gonorrhoeae. On the other hand, there have been only two reports of plasmid-mediated cephalosporinases, from Proteus mirabilis (2) and Achromobacter spp. (14) .
We evaluated the possible resistance mechanisms of oxyimino-cephalosporin-resistant Escherichia coli isolated from the fecal flora of laboratory dogs, and we identified a 3-lactamase which hydrolyzes oxyimino-cephalosporins such as cefuroxime, cefotaxime, cefmenoxime, and ceftriaxone in addition to cephaloridine. The physiological properties of this enzyme were quite distinct from those of chromosomal cephalosporinases from E. coli (20, 23) . We confirmed that this enzyme was plasmid mediated and had properties similar to those of oxyimino-cephalosporinase type I (7) .
MATERIALS AND METHODS
Bacterial strains. E. coli FP1546 was isolated from the fecal flora of a laboratory dog being used for pharmacokinetic studies of P-lactam antibiotics. The nalidixic acidresistant derivative of E. coli CSH2 (metB F-) was kindly provided by T. Yokota of Juntendo University.
Antibiotics. Commercially available cephaloridine, cephalothin, cefamandole, cefotiam, cefmetazole, cefsulodin, cefuroxime, cefotaxime, cefmenoxime, ceftriaxone, ceftazidime, cefoperazone, cefpiramide, cefoxitin, moxalactam, and imipenem were used. Cefazolin and ceftizoxime were from Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan. were harvested by centrifugation, washed once, and suspended in 0.067 M potassium phosphate buffer (pH 7.0). The cell suspension was sonicated, yielding a lysate, and then partially purified by gel filtration (Sephadex G100; Pharmacia AB, Uppsala, Sweden), using a previously described method (25) .
Assay of I-lactamase activity. 3-Lactamase activity was determined spectrophotometrically (Hitachi 220A) at 37°C in 0.067 M phosphate buffer (pH 7.0). P-Lactamase inhibitor susceptibility. Serial dilutions of a 3-lactamase inhibitor were incubated with enzyme solution for 10 min at 37°C. Residual 3-lactamase activity was determined spectrophotometrically, using the chromogenic substrate nitrocefin at 482 nm. The concentration inhibiting 50% of activity was calculated.
Isoelectric focusing. Isoelectric focusing of the cell lysate, using Ampholine (LKB Stockholm, Bromma, Sweden)-polyacrylamide gel, was done. 1-Lactamase bands were detected by zymogram, using nitrocefin (22) .
Molecular weight determination. Enzyme molecular weight was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (13). 3-Lactamases and marker proteins were boiled for 2 min in 1% sodium dodecyl sulfate-3% 2-mercaptoethanol before application. A low-molecularweight calibration kit (Pharmacia AB, Uppsala, Sweden) was used. Transconjugation method. Previously described broth and filter-mating techniques were used (27) . E. coli FP1546 and E. coli CSH2 Nalr (recipient) were incubated for 6 h at 37°C before selection of transconjugant.
ANTIMICROB. AGENTS CHEMOTHER. 7). Enzymatic inhibition. The ,-lactamase from E. coli FP1546 was greatly inhibited by clavulanic acid, sulbactam, and imipenem, with respective 50% inhibitory concentrations of 0.0093, 0.020, and 0.41 ,uM. These results also suggest its classification as an oxyimino-cephalosporinase type I enzyme (7).
Transfer of cephem resistance. Because apparent properties of this 3-lactamase differ considerably from those of chromosomal cephalosporinases produced by other E. coli strains (20, 23) , the enzyme is possibly plasmid mediated. Cephem-resistant transconjugants were obtained by both broth and filter-mating methods at frequencies of 10-6 and 2.5 x 10-5, respectively. The MICs of various antibiotics for the donor, recipient, and transconjugant are shown in Table  1 . Cephem resistance was fully expressed in the transconjugant, which produced a P-lactamase with the same pl as that of FEC-1.
Identification of plasmid DNA. Plasmid DNA was purified from donor and transconjugant and analyzed by agarose gel electrophoresis. Donor and transconjugant had the same size plasmid, pFCX1. pFCX1 was estimated to be about 78 megadaltons from the sum of the fragments cleaved by restriction enzymes. pFCX1 did not encode a gene for resistance to other antibiotics such as aminoglycosides, chloramphenicol, sulfamethoxazole, tetracyclines, and trimethoprim (data not shown) or to Hg2" (Table 1) .
DISCUSSION
Inactivation by ,-lactamases is the most frequent cause of P-lactam antibiotic resistance in clinically isolated gramnegative bacteria (17, 21) . In E. coli, many plasmid-mediated penicillinases have already been isolated, and elevated levels of chromosomal cephalosporinase also have resulted in resistance (9, 11) . However, so-called broad-spectrum oxyimino-cephalosporins such as ceftizoxime and cefotaxime are active against these P-lactam-resistant E. coli.
E. coli FP1546 is unusually resistant to various P-lactam antibiotics including the oxyimino-cephalosporins. Characterization of a ,-lactamase designated FEC-1 produced by this strain revealed that it is a type I P-lactamase which hydrolyzes oxyimino-cephalosporins (7). Of great interest, FEC-1 is plasmid mediated and can be transferred to another E. coli strain by conjugation. Thus, the major mechanism of E. coli FP1546 cephem resistance appears to be production of 3-lactamase FEC-1, based on the fact that transfer of plasmid pFCX1 produced full expression of P-lactam resistance without resistance to other antibiotics.
Although the origin of this novel plasmid-mediated Ilactamase FEC-1 gene is as yet unknown, quite probably it comes from canine intestinal bacterial flora. Oxyiminocephalosporinase type I-producing microflora such as Bacteroides spp., K. oxytoca, and P. vulgaris are most likely. Worth consideration is Bacteroides fragilis, in which conjugative transfer of P-lactamase in the absence of plasmid has been reported (4), and the possible transfer of a resistance gene to other species cannot be excluded.
Plasmid-mediated 3-lactamase FEC-1 could be the result of a "selective pressure" process, arising from the various P-lactam antibiotics which have been given to those dogs used routinely for kinetic experiments; we isolated E. coli FP1546 from such animals. This kind of "selection" may possibly be seen eventually in clinical practice, with occurrence of resistant strains such as E. coli FP1546 increasing in the future. In fact, plasmid-mediated ,-lactamases which hydrolyze broad-spectrum cephalosporins have been reported recently (1, 3, 10, 26) , although they are of the penicillinase type.
It is of interest that ceftizoxime has moderate activity againt E. coli FP1546 among the tested oxyimino-cephalosporin derivatives, in contrast to the lack of activity seen with cefotaxime, cefmenoxime, and ceftriaxone. The latter three drugs had no activity against this strain, although they have the same structure {7,B-[(Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido]} at the 7 position of the cephalosporin nucleus. We need to monitor continuously the trend toward isolation of this kind of resistant strain and its clinical implications.
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